Edesa Biotech Inc (NQ: EDSA )
Press Releases about Edesa Biotech Inc
Edesa Biotech Reports Fiscal 1st Quarter 2024 Results
February 09, 2024
Edesa Biotech Reports Fiscal Year 2023 Results
December 15, 2023
Edesa Biotech Reports Final Phase 2b Results for Dermatitis Study
November 20, 2023
Edesa Biotech to Present at Dermatology Drug Development Summit
October 26, 2023
Edesa Biotech Announces One-for-Seven Reverse Share Split
October 10, 2023
Edesa Biotech Publishes Phase 2 Substudy Results of ARDS Drug Candidate
September 28, 2023
Edesa Biotech Reports Fiscal Third Quarter 2023 Results
August 09, 2023
Edesa Biotech Appoints Biotech Deal Veteran to CFO Role
June 27, 2023
Edesa Biotech to Participate in Swiss Biotech Day
April 20, 2023
Edesa Biotech Reports Fiscal 1st Quarter 2023 Results
February 10, 2023
Edesa Biotech Receives Regulatory Approval for Phase 2 Vitiligo Study
February 01, 2023
Edesa Biotech Reports Topline Phase 2b Results for Dermatology Drug
January 17, 2023
FDA Grants Fast Track to Edesa Biotech's ARDS Drug Candidate
December 20, 2022
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.